Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
29.35
-2.19 (-6.94%)
At close: Apr 28, 2026, 4:00 PM EDT
29.11
-0.24 (-0.83%)
After-hours: Apr 28, 2026, 5:36 PM EDT
Sensei Biotherapeutics Employees
As of December 31, 2024, Sensei Biotherapeutics had 15 total employees, including 14 full-time and 1 part-time employees. The number of employees decreased by 13 or -46.43% compared to the previous year.
Employees
15
Change (1Y)
-13
Growth (1Y)
-46.43%
Revenue / Employee
n/a
Profits / Employee
-$1,405,667
Market Cap
39.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 15 | -13 | -46.43% |
| Dec 31, 2023 | 28 | 0 | - |
| Dec 31, 2022 | 28 | -28 | -50.00% |
| Dec 31, 2021 | 56 | 24 | 75.00% |
| Dec 31, 2020 | 32 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Aligos Therapeutics | 82 |
| Werewolf Therapeutics | 39 |
| Mereo BioPharma Group | 39 |
| Plus Therapeutics | 28 |
| Actinium Pharmaceuticals | 25 |
| Atara Biotherapeutics | 14 |
| Rallybio | 14 |
| Rein Therapeutics | 10 |
SNSE News
- 12 days ago - Sensei Biotherapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 19 days ago - Sensei Biotherapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference - Business Wire
- 4 weeks ago - Sensei Biotherapeutics Reports Full Year 2025 Financial Results and Provides Corporate Update - Business Wire
- 6 weeks ago - Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 2 months ago - Sensei Biotherapeutics Transcript: M&A announcement - Transcripts
- 2 months ago - Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement - Business Wire
- 3 months ago - Egle Therapeutics Appoints John Celebi as Chief Executive Officer - GlobeNewsWire
- 5 months ago - Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire